We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIXTW
14351
DELISTED
Lixte Biotechnology Warrants
LIXTW
$664 ﹤0.01%
+11,067
New +$1.26K
AVHIW
14352
DELISTED
Achari Ventures Holdings Corp I Warrant
AVHIW
$661 ﹤0.01%
+15,526
New +$880
NWG icon
14353
PUT
NatWest
NWG
$76B
$660 ﹤0.01%
100
-84
-46% -$593
VIVS
14354
PUT
VivoSim Labs
VIVS
$1.13M
$657 ﹤0.01%
+25
New +$597
TRI icon
14355
Thomson Reuters
TRI
$44.9B
$651 ﹤0.01%
+5
New +$637
SGTX
14356
PUT
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$651 ﹤0.01%
+54
New +$561
XELA
14357
PUT
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$642 ﹤0.01%
83
-89
-52% -$1.08K
MAGN
14358
CALL
Magnera Corp
MAGN
$444M
$638 ﹤0.01%
15
-185
-93% -$8.53K
HEXO
14359
PUT
DELISTED
HEXO Corp. Common Shares
HEXO
$637 ﹤0.01%
475
-92
-16% -$134
KRRO icon
14360
Korro Bio
KRRO
$196M
$625 ﹤0.01%
25
-792
-97% -$90.2K
KNTE
14361
PUT
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$625 ﹤0.01%
100
NAVB
14362
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$624 ﹤0.01%
2,400
-7,700
-76% -$2.25K
CEMI
14363
DELISTED
Chembio diagnostics, Inc.
CEMI
$623 ﹤0.01%
1,409
-19,486
-93% -$7.64K
PEARW
14364
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$621 ﹤0.01%
+32,668
New +$3.15K
FSRXW
14365
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$619 ﹤0.01%
+16,723
New +$691
OTMOW
14366
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$618 ﹤0.01%
+16,697
New +$594
OPTXW icon
14367
Syntec Optics Holdings Warrant
OPTXW
$21.4M
$611 ﹤0.01%
+13,000
New +$755
DOMA
14368
CALL
DELISTED
Doma Holdings, Inc.
DOMA
$611 ﹤0.01%
+60
New +$807
OSUR icon
14369
PUT
OraSure Technologies
OSUR
$265M
$605 ﹤0.01%
100
-18,400
-99% -$104K
GNSS icon
14370
PUT
Genasys
GNSS
$78.8M
$590 ﹤0.01%
+200
New +$714
LCUT icon
14371
CALL
Lifetime Brands
LCUT
$226M
$588 ﹤0.01%
100
-100
-50% -$713
ABTS icon
14372
PUT
Abits Group
ABTS
$3.91M
$582 ﹤0.01%
40
-440
-92% -$6.85K
ETWO
14373
PUT
DELISTED
E2open Parent Holdings
ETWO
$582 ﹤0.01%
100
-2,500
-96% -$15.1K
CRWS icon
14374
PUT
Crown Crafts
CRWS
$30.7M
$578 ﹤0.01%
+100
New +$569
ATAI icon
14375
AtaiBeckley Inc
ATAI
$2.69B
$567 ﹤0.01%
313
-12,590
-98% -$21.3K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.